Skip to main content
Erschienen in: Die Diabetologie 5/2022

31.05.2022 | Typ-2-Diabetes | Journal Club

Vergleich schwerwiegender kardiovaskulärer Ereignisse, schwerer Hypoglykämien und Gesamtmortalität zwischen pankreoprivem Diabetes mellitus und Typ-2-Diabetes

verfasst von: Dr. Michael Jecht

Erschienen in: Die Diabetologie | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Auszug

Olesen SS, Viggers R, Drewes AM et al (2022) Risk of major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality in postpancreatitis diabetes mellitus versus type 2 diabetes: a nationwide population-based cohort study. Diabetes Care. https://​doi.​org/​10.​2337/​dc21-2531. …
Literatur
1.
Zurück zum Zitat Hart PA, Bellin MD, Andersen DK et al (2016) Consortium for the study of chronic Pancreatitis, diabetes, and pancreatic cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1:226–237CrossRef Hart PA, Bellin MD, Andersen DK et al (2016) Consortium for the study of chronic Pancreatitis, diabetes, and pancreatic cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1:226–237CrossRef
2.
Zurück zum Zitat Petrov MS (2021) Diagnosis of endocrine disease: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol 184:R137–R149CrossRef Petrov MS (2021) Diagnosis of endocrine disease: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol 184:R137–R149CrossRef
3.
Zurück zum Zitat Petrov MS, Yadav D (2019) Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 16:175–184CrossRef Petrov MS, Yadav D (2019) Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 16:175–184CrossRef
4.
Zurück zum Zitat Cho J, Petrov MS (2020) Pancreatitis, pancreatic cancer, and their metabolic sequelae: projected burden to 2050. Clin Transl Gastroenterol 11:e251CrossRef Cho J, Petrov MS (2020) Pancreatitis, pancreatic cancer, and their metabolic sequelae: projected burden to 2050. Clin Transl Gastroenterol 11:e251CrossRef
5.
Zurück zum Zitat Woodmansey C, McGovern AP, McCullough KA et al (2017) Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care 40:1486–1493CrossRef Woodmansey C, McGovern AP, McCullough KA et al (2017) Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care 40:1486–1493CrossRef
6.
Zurück zum Zitat Viggers R, Jensen MH, Laursen HVB, Drewes AM, Vestergaard P, Olesen SS (2021) Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study. Diabetes Care 44:2045–2052CrossRef Viggers R, Jensen MH, Laursen HVB, Drewes AM, Vestergaard P, Olesen SS (2021) Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study. Diabetes Care 44:2045–2052CrossRef
7.
Zurück zum Zitat Olesen SS, Svane HML, Nicolaisen SK et al (2021) Clinical and biochemical characteristics of postpancreatitis diabetes mellitus: a crosssectional study from the Danish nationwide DD2 cohort. J Diabetes 13:960–974CrossRef Olesen SS, Svane HML, Nicolaisen SK et al (2021) Clinical and biochemical characteristics of postpancreatitis diabetes mellitus: a crosssectional study from the Danish nationwide DD2 cohort. J Diabetes 13:960–974CrossRef
8.
Zurück zum Zitat Monnier L, Colette C, Owens D (2021) Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the „Gordian Knot“? Diabetes Metab 47:101225CrossRef Monnier L, Colette C, Owens D (2021) Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the „Gordian Knot“? Diabetes Metab 47:101225CrossRef
9.
Zurück zum Zitat Cho J, Scragg R, Petrov MS (2019) Risk of mortality and hospitalization after post-pancreatitis diabetes mellitus vs type 2 diabetes mellitus: a populationbased matched cohort study. Am J Gastroenterol 114:804–812CrossRef Cho J, Scragg R, Petrov MS (2019) Risk of mortality and hospitalization after post-pancreatitis diabetes mellitus vs type 2 diabetes mellitus: a populationbased matched cohort study. Am J Gastroenterol 114:804–812CrossRef
10.
Zurück zum Zitat Lin C‑H, Yeh N‑C, Wang J‑J et al (2020) Effect of chronic pancreatitis on complications and mortality in DM patients: a 10-year nationwide cohort study. J Clin Endocrinolmetab 105:e739–e745CrossRef Lin C‑H, Yeh N‑C, Wang J‑J et al (2020) Effect of chronic pancreatitis on complications and mortality in DM patients: a 10-year nationwide cohort study. J Clin Endocrinolmetab 105:e739–e745CrossRef
Metadaten
Titel
Vergleich schwerwiegender kardiovaskulärer Ereignisse, schwerer Hypoglykämien und Gesamtmortalität zwischen pankreoprivem Diabetes mellitus und Typ-2-Diabetes
verfasst von
Dr. Michael Jecht
Publikationsdatum
31.05.2022
Verlag
Springer Medizin
Erschienen in
Die Diabetologie / Ausgabe 5/2022
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-022-00918-0

Weitere Artikel der Ausgabe 5/2022

Die Diabetologie 5/2022 Zur Ausgabe

Einführung zum Thema

Diabetes Update 2022

Mitteilungen des BDE

Mitteilungen des BDE

Mitteilungen des BDI

Mitteilungen des BDI

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.